Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
Journal article
Mokaya J. et al, (2021), Journal of Viral Hepatitis, 28, 1110 - 1120
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
Therapeutic vaccination for treatment of chronic hepatitis B.
Journal article
Cargill T. and Barnes E., (2021), Clinical and experimental immunology, 205, 106 - 118
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Journal article
Liu C. et al, (2021), Cell
High cure rates for HCV genotype 6 in advanced liver fibrosis with 12 weeks sofosbuvir and daclatasvir: The Vietnam SEARCH Study
Journal article
Flower B. et al, (2021), Open Forum Infectious Diseases
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy
Journal article
Smith DA. et al, (2021), Journal of Viral Hepatitis
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Working paper
Ahern DJ. et al, (2021)
Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID‐19 patients as prognostic markers
Journal article
Wang T. et al, (2021), Hepatology Communications
COVID-19 and liver disease: mechanistic and clinical perspectives.
Journal article
Marjot T. et al, (2021), Nat Rev Gastroenterol Hepatol
Antibody evasion by the P.1 strain of SARS-CoV-2
Journal article
Dejnirattisai W. et al, (2021), Cell
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Journal article
Voysey M. et al, (2021), The Lancet, 397, 881 - 891
The rs738409 G allele in PNPLA3 is associated with a reduced risk of COVID-19 mortality and hospitalisation.
Journal article
Innes H. et al, (2021), Gastroenterology
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.
Journal article
Webb GJ. et al, (2021), J Hepatol
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Journal article
Zhou D. et al, (2021), Cell
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Journal article
Supasa P. et al, (2021), Cell
Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Conference paper
Cooke GS. et al, (2021)
SARS-CoV-2 infection in patients with autoimmune hepatitis.
Journal article
Marjot T. et al, (2021), Journal of hepatology
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.
Journal article
Marjot T. et al, (2021), Lancet Gastroenterol Hepatol